Patent Assignment
Reel/Frame 031157/0186
Release of Security Interest
Recorded: 2013-09-04
Pages: 14
Assignor
WELLS FARGO FOOTHILL, LLC
Executed: 2013-08-05
Assignees
ANGIOTECH PHARMACEUTICALS, INC.
355 BURRARD STREET, SUITE 1100, VANCOUVER, BC, V6C 2G8, CANADA
ANGIOTECH AMERICA, INC.
355 BURRARD STREET, SUITE 1100, C/O ANGIOTECH PHARMACEUTICALS, INC., VANCOUVER, BC, V6C 2GB, CANADA
SURGICAL SPECIALTIES CORPORATION (US), INC., FORMERLY KNOWN AS ANGIOTECH PHARMACEUTICALS (US), INC.
355 BURRARD STREET, SUITE 1100, C/O ANGIOTECH PHARMACEUTICALS, INC., VANCOUVER, BC, V6C 2GB, CANADA
B.G. SULZLE, INC.
355 BURRARD STREET, SUITE 1100, C/O ANGIOTECH PHARMACEUTICALS, INC., VANCOUVER, BC, V6C 2GB, CANADA
QUILL MEDICAL, INC.
355 BURRARD STREET, SUITE 1100, C/O ANGIOTECH PHARMACEUTICALS, INC., VANCOUVER, BC, V6C 2GB, CANADA
SURGICAL SPECIALTIES CORPORATION
355 BURRARD STREET, SUITE 1100, C/O ANGIOTECH PHARMACEUTICALS, INC., VANCOUVER, BC, V6C 2GB, CANADA
ANGIOTECH INTERNATIONAL HOLDINGS CORP.
355 BURRARD STREET, SUITE 1100, C/O ANGIOTECH PHARMACEUTICALS, INC., VANCOUVER, BC, V6C 2GB, CANADA
Covered Properties
(48)
Biocompatible Crosslinked Hydrogels, Drug-Loaded Hydrogels and Methods of Using the Same
PCT:
PCT/US2009/041469 ↗
Composition and Method for Treatment of Dermal Inflammation
Patent:
4,959,205 →
Application:
07/327,488 →
Collagen Wound Healing Matrices and Process for Their Production
Patent:
5,219,576 →
Application:
07/801,732 →
Human Recombinant Collagen in the Milk of Transgenic Animals
Patent:
5,667,839 →
Application:
08/183,648 →
Method of Controlling Structure Stability of Collagen Fibers Produced Form Solutions or Dispersions Treated with Sodium Hydroxide for Infectious Agent Deactivation
Patent:
5,616,689 →
Application:
08/274,673 →
Mutated Recombinant Collagens
Patent:
6,653,450 →
Application:
08/278,774 →
Method of Preparing Crosslinked Biomaterial Compositions for Use in Tissue Augmentation
Patent:
5,550,187 →
Application:
08/287,549 →
Anti-Adhesion Films and Compositions for Medical Use
Patent:
5,580,923 →
Application:
08/403,360 →
Affinity Bound Collagen Matrices for the Delivery of Biologically Active Agents
Patent:
5,693,341 →
Application:
08/405,320 →
Implants Coated with Collagen-Polymer Conjugates
Patent:
5,543,441 →
Application:
08/427,576 →
Prion Inactivation in Connective Tissue Materials
Patent:
5,756,678 →
Application:
08/431,950 →
Method of Preparing Crosslinked Biomaterial Compositions for Use in Tissue Augmentation
Patent:
5,527,856 →
Application:
08/440,274 →
Anti-Angiogenic Compositions and Methods of Use
Patent:
5,886,026 →
Application:
08/472,413 →
Production of Human Recombinant Collagen in the Milk of Transgenic Mammals
Patent:
5,962,648 →
Application:
08/473,465 →
Anti-Angiogenic Compositions and Methods of Use
Patent:
5,716,981 →
Application:
08/478,203 →
Collagen-Polymer Conjugates
Patent:
5,550,188 →
Application:
08/478,510 →
Anti-Angiogenic Compositions and Methods for the Treatment of Arthritis
Patent:
5,994,341 →
Application:
08/478,914 →
Production of Collagen in the Milk of Transgenic Mammals
Patent:
6,713,662 →
Application:
08/482,173 →
Production of Human Recombinant Collagen in the Milk of Transgenic Animals
Patent:
5,895,833 →
Application:
08/485,194 →
Collagen-Based Injectable Drug Delivery System and Its Use
Patent:
5,807,581 →
Application:
08/537,073 →
Injectable or Implantable Biomaterials for Filling or Blocking Lumens and Voids of the Body
Patent:
5,752,974 →
Application:
08/574,050 →
Method for Sterile Syringe Packaging and Handling
Patent:
5,997,811 →
Application:
08/886,957 →
Cell Separation Device and Metering Syringe
Patent:
6,123,687 →
Application:
09/032,347 →
Compositions Containing Thrombin and Microfibrillar Nanometer Collagen, and Methods for Preparation and Use Thereof
Patent:
6,096,309 →
Application:
09/099,126 →
Expression of Procollagen in Yeast
Patent:
6,472,171 →
Application:
09/120,561 →
Collagen-Polymer Matrices with Differential Biodegradability
Patent:
6,110,484 →
Application:
09/199,139 →
Novel Methods for the Production of Gelatin and Full-Length Triple Helical Collagen in Recombinant Cells
Patent:
6,428,978 →
Application:
09/289,578 →
Crosslinkable Biomaterial Compositions Containing Hydrophobic and Hydrophilic Crosslinking Agents
Patent:
6,962,979 →
Application:
09/344,230 →
Compositions Containing Thrombin and Microfibillar Collagen and Methods for Preparation and Use Thereof
Patent:
6,280,727 →
Application:
09/436,903 →
Apparatuses, Methods and Compositions for Closing Tissue Puncture Openings
Patent:
6,482,179 →
Application:
09/578,814 →
Recombinant Gelatin and Full-Length Triple Helical Collagen
Patent:
6,413,742 →
Application:
09/585,887 →
Collagen-polymer matrices with differential biodegradability
Patent:
6,277,394 →
Application:
09/596,183 →
Ecarin Polypeptides, Polynucleotides Encoding Ecarin, and Methods for Use Thereof
Patent:
6,413,737 →
Application:
09/608,790 →
Compositions and Methods for Treating or Preventing Diseases of Body Passageways
Sealant Plug Delivery Methods
Patent:
6,790,185 →
Application:
10/248,261 →
Use of Hydrophobic Crosslinking Agents to Prepare Crosslinked Biomaterial Compositions
Surgical Knife Blade with Hollow Bevel
Mixing and Dispensing Fluid Components of a Multicomponent Composition
Anti-Angiogenic Compositions and Methods of Use
Adhesive Tissue Repair Patch
Multifunctional Compounds for Forming Crosslinked Biomaterials and Methods of Preparation and Use
Sutures and Anti-Scarring Agents
Application:
12/162,572 →
Publication:
US 2009/0226500
Mixing and Dispensing Fluid Components of a Multicomponent Composition
Sheath for Intravascular Inflatable Structures, for Example to Expand Stents
Application:
12/266,053 →
Publication:
US 2009/0125094
Anti-Infective Catheters
Application:
61/030,850 →
Biocompatible Crosslinked Hydrogels and Methods of Using the Same
Application:
61/046,920 →
Biocompatible Crosslinked Hydrogels with Pharmaceuticals and Methods of Using the Same
Application:
61/046,954 →
Anti-Infective Catheters
Application:
61/047,033 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 29, 2013
From: ANGIOTECH PHARMACEUTICALS (US), INC.
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 031510/0399 →
Security Interest
Dec 7, 2016
From: PHARMING B.V.
To: SILICON VALLEY BANK
Reel/Frame 040593/0963 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Security Interest
Mar 10, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: VIRTUS GROUP, LP
Reel/Frame 041539/0864 →
Assignment of Assignor's Interest
Mar 28, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: SURGICAL SPECIALTIES CORPORATION LIMITED
Reel/Frame 042115/0140 →
Security Interest
Apr 5, 2017
From: SURGICAL SPECIALTIES CORPORATION LIMITED
To: VIRTUS GROUP, LP
Reel/Frame 041860/0980 →
Partial Release of Security Interest
Apr 5, 2017
From: VIRTUS GROUP, LP
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 042166/0029 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0151 →
Corrective Assignment to Correct the Assignee Address Previously Recorded on Reel 042115 Frame 0140. Assignor(S) Hereby Confirms the Assignment.
Aug 8, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: SURGICAL SPECIALTIES CORPORATION LIMITED
Reel/Frame 043332/0360 →
Release of Security Interest
May 7, 2019
From: VIRTUS GROUP, LP, AS ADMINISTRATIVE AGENT FOR THE LENDERS
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 049106/0137 →
Release of Security Interest
May 7, 2019
From: VIRTUS GROUP, LP, AS ADMINISTRATIVE AGENT FOR THE LENDERS
To: SURGICAL SPECIALTIES CORPORATION LIMITED
Reel/Frame 049106/0173 →
Security Interest
May 26, 2019
From: ANGIOTECH PHARMACEUTICALS, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049288/0184 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →
Release of Security Interest : Recorded at Reel/Frame - 049288/0184
Jan 29, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 055171/0634 →